FDA Week - 01/11/2019

FDA Plans To Make Sentinel ‘Transformative National Resource’ By 2023

January 09, 2019
Over the next five years, FDA hopes to grow its electronic safety surveillance system, known as Sentinel, into a national data and scientific resource that functions as a multi-purpose center for evidence generation, FDA Commissioner Scott Gottlieb wrote in an FDA Voice blog on Wednesday (Jan. 9). To make this a reality by 2023, the agency lays out in a strategy document five strategic goals , which include: using Sentinel to accelerate access to and broaden use of real-world...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.